JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins >> BioPharma Services >> CDMO >> Services >> Clinical Trial Material, Packaging & Logistics >> Direct To Patient

Direct To Patient

Sidebar Image

Eurofins CDMO network of companies set up worldwide Direct-To-Patients solutions to enable sponsors to speed up the enrollment in their clinical trials, increase patients engagement and adherence particularly during lengthy and complex studies by facilitating their life with home delivery and home care services.

The strong benefits of the Direct-To-Patients approach in Clinical Trials are fully established with a strong acceleration linked to COVID crisis:

For Patients:
  • Reduced travels 
  • Reduced number of clinic visits
  • Improved Quality of Life
For Sponsors:
  • Increased enrollment rates
  • Lower dropout rates of patients
  • Decreased cost per patient
  • Guaranteed chain of custody and temperature

 

For further details, please contact us!